111 related articles for article (PubMed ID: 10023444)
1. Astrocyte-specific expression of tyrosine hydroxylase after intracerebral gene transfer induces behavioral recovery in experimental parkinsonism.
Segovia J; Vergara P; Brenner M
Gene Ther; 1998 Dec; 5(12):1650-5. PubMed ID: 10023444
[TBL] [Abstract][Full Text] [Related]
2. Primary astrocytes retrovirally transduced with a tyrosine hydroxylase transgene driven by a glial-specific promoter elicit behavioral recovery in experimental parkinsonism.
Cortez N; Trejo F; Vergara P; Segovia J
J Neurosci Res; 2000 Jan; 59(1):39-46. PubMed ID: 10658184
[TBL] [Abstract][Full Text] [Related]
3. [Intracerebral grafting of ex vivo transgene muscle cells in rat model of parkinsonism].
Xu Q; Tian J; Zhang J
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):5-9. PubMed ID: 10374497
[TBL] [Abstract][Full Text] [Related]
4. Generation of DOPA-producing astrocytes by retroviral transduction of the human tyrosine hydroxylase gene: in vitro characterization and in vivo effects in the rat Parkinson model.
Lundberg C; Horellou P; Mallet J; Björklund A
Exp Neurol; 1996 May; 139(1):39-53. PubMed ID: 8635567
[TBL] [Abstract][Full Text] [Related]
5. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain.
Kaplitt MG; Leone P; Samulski RJ; Xiao X; Pfaff DW; O'Malley KL; During MJ
Nat Genet; 1994 Oct; 8(2):148-54. PubMed ID: 7842013
[TBL] [Abstract][Full Text] [Related]
6. Long term gene therapy of Parkinson's disease using immortalized rat glial cell line with tyrosine hydroxylase gene.
Zhuo M; Xu DH; Cao L; Xu LF; Yu FR; Zheng ZC; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1066-71. PubMed ID: 14673496
[TBL] [Abstract][Full Text] [Related]
7. Intravenous glial-derived neurotrophic factor gene therapy of experimental Parkinson's disease with Trojan horse liposomes and a tyrosine hydroxylase promoter.
Xia CF; Boado RJ; Zhang Y; Chu C; Pardridge WM
J Gene Med; 2008 Mar; 10(3):306-15. PubMed ID: 18085726
[TBL] [Abstract][Full Text] [Related]
8. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.
Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF
Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539
[TBL] [Abstract][Full Text] [Related]
9. [Intracerebral transplantation of genetically modified cells for Parkinson's disease].
Tang Z; Ying Q; Peng L
Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):10-2. PubMed ID: 10374498
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy in a rodent model of Parkinson's disease using differentiated C6 cells expressing a GFAP-tyrosine hydroxylase transgene.
Trejo F; Vergara P; Brenner M; Segovia J
Life Sci; 1999; 65(5):483-91. PubMed ID: 10462075
[TBL] [Abstract][Full Text] [Related]
11. Reversible neurochemical changes mediated by delayed intrastriatal glial cell line-derived neurotrophic factor gene delivery in a partial Parkinson's disease rat model.
Yang X; Mertens B; Lehtonen E; Vercammen L; Bockstael O; Chtarto A; Levivier M; Brotchi J; Michotte Y; Baekelandt V; Sarre S; Tenenbaum L
J Gene Med; 2009 Oct; 11(10):899-912. PubMed ID: 19639608
[TBL] [Abstract][Full Text] [Related]
12. Selective astrocytic transgene expression in vitro and in vivo from the GFAP promoter in a HSV RL1 null mutant vector--potential glioblastoma targeting.
McKie EA; Graham DI; Brown SM
Gene Ther; 1998 Apr; 5(4):440-50. PubMed ID: 9614567
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of bone marrow stromal cells containing the neurturin gene in rat model of Parkinson's disease.
Ye M; Wang XJ; Zhang YH; Lu GQ; Liang L; Xu JY; Chen SD
Brain Res; 2007 Apr; 1142():206-16. PubMed ID: 17336273
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.
Bensadoun JC; Déglon N; Tseng JL; Ridet JL; Zurn AD; Aebischer P
Exp Neurol; 2000 Jul; 164(1):15-24. PubMed ID: 10877911
[TBL] [Abstract][Full Text] [Related]
15. Long-term correction of rat model of Parkinson's disease by gene therapy.
Jiao S; Gurevich V; Wolff JA
Nature; 1993 Apr; 362(6419):450-3. PubMed ID: 8096625
[TBL] [Abstract][Full Text] [Related]
16. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
Cunningham LA; Su C
Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
[TBL] [Abstract][Full Text] [Related]
17. [Expression of foreign tyrosine hydroxylase gene in the rat model of Parkinson's disease].
Jiang ZH; Ni ZM; Zhou CF; Cao L; Zheng ZC; Liu XY; Zhao YC; Chen SD
Sheng Li Xue Bao; 1997 Apr; 49(2):141-5. PubMed ID: 9812848
[TBL] [Abstract][Full Text] [Related]
18. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.
Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R
J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cDNA and genomic forms of tyrosine hydroxylase gene therapy of the brain with Trojan horse liposomes.
Xia CF; Chu C; Li J; Wang Y; Zhang Y; Boado RJ; Pardridge WM
J Gene Med; 2007 Jul; 9(7):605-12. PubMed ID: 17471587
[TBL] [Abstract][Full Text] [Related]
20. Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.
Bouchez G; Sensebé L; Vourc'h P; Garreau L; Bodard S; Rico A; Guilloteau D; Charbord P; Besnard JC; Chalon S
Neurochem Int; 2008 Jun; 52(7):1332-42. PubMed ID: 18372079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
